Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2015-03-31
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A New Device for Measuring of Lung Photoplethysmography and Pulmonic Arterial Saturation
NCT02894970
Splanchnic and Renal Tissue Oxygenation During Enteral Feedings in Neonates With Patent Ductus Arteriosus
NCT03551600
Patent Ductus Arteriosus and Splanchnic Oxygenation at First Feed
NCT03723889
NIRS in PDA VLBW Infants
NCT02396004
Alternative Paracetamol Treatments for the Neonate With a hsPDA
NCT03604796
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Term
Normal Term Newborn Intervention: PPG
PPG
A PPG device will be applied to subjects in the right hand, left hand and one of the legs. Data will be recorded into a computer software
Preterm
Preterm babies admitted to the NICU not suffering from the conditions to be studied Intervention: PPG
PPG
A PPG device will be applied to subjects in the right hand, left hand and one of the legs. Data will be recorded into a computer software
PDA
Patent Ductus Arteriosus Intervention: PPG
PPG
A PPG device will be applied to subjects in the right hand, left hand and one of the legs. Data will be recorded into a computer software
PPHN
Persistent Pulmonary Hypertension Intervention: PPG
PPG
A PPG device will be applied to subjects in the right hand, left hand and one of the legs. Data will be recorded into a computer software
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PPG
A PPG device will be applied to subjects in the right hand, left hand and one of the legs. Data will be recorded into a computer software
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
3 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shaare Zedek Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ruben Bromiker, MD
Role: PRINCIPAL_INVESTIGATOR
Shaare Zedek Medical Center, Jerusalem, Israel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ruben Bromiker
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Nitzan I, Hammerman C, Fink D, Nitzan M, Koppel R, Bromiker R. The effect of patent ductus arteriosus on pre-ductal and post-ductal perfusion index in preterm neonates. Physiol Meas. 2018 Jul 20;39(7):075006. doi: 10.1088/1361-6579/aacf25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
181/14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.